Suchergebnisse - "Ma, Liang-Ming"

PubPharm (32)

1

Comparison of Plerixafor or Cyclophosphamide Combined with G-CSF in Mobilization of Peripheral Blood Stem Cells in Multiple Myeloma

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2023

von Li, W. | Ma, L. | Lian, Y. | +3

2

Analysis of Pathogenic Bacterial Spectrum, Drug Resistance and Risk Factors for Mortality of Bloodstream Infection in Patients with Hematologic Diseases

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2023

von Guo, Q. | Wang, X. | Chen, X. | +4

3

A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning : a nationwide prospective cohort study

enthalten in: Science bulletin | 2023

von An, Z. | Wu, Y. | Hou, Y. | +65

4

Efficacy of Activated Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2023

von Ren, R. | Ma, L. | Wang, T. | +6

5

Clinical Characteristics and Risk Factors for 30-Day Mortality in Patients with Hematologic Diseases Infected by Carbapenem-Resistant Organisms

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2023

von Chen, X. | Hou, C. | Zhao, J. | +7

6

A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria

enthalten in: The Lancet regional health. Western Pacific | 2023

von Zhang, L. | Dong, Y. | Peng, H. | +40

7

Clinical Characteristics and Nomogram Model of Nosocomial Infection in Patients with Newly Diagnosed Multiple Myeloma

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2023

von Lu, X. | Yao, Q. | Yang, L. | +5

8

Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma : a real-world multi-centered study in China

enthalten in: Frontiers in oncology | 2023

von Zhuang, Z. | Tian, Y. | Shi, L. | +18

9

The impact of second-donor lymphocyte infusion on secondary graft failure after allogeneic hematopoietic stem cell transplantation through activation of Foxp3 and regulatory T cells

enthalten in: Cytotherapy | 2022

von Xie, Y. | Ma, L. | Ren, R. | +2

RetractionIn: Cytotherapy. 2023 May;25(5):559. - PMID 36934042

10

Developing and validating a mortality prediction model for ICH in ITP : a nationwide representative multicenter study

enthalten in: Blood advances | 2022

von Chong, S. | Zhao, P. | Huang, R. | +37